Prerequisite endocardial-mesenchymal transition for murine cardiac trabecular angiogenesis

Dev Cell. 2023 May 8;58(9):791-805.e4. doi: 10.1016/j.devcel.2023.03.009. Epub 2023 Apr 5.

Abstract

Coronary heart disease damages the trabecular myocardium, and the regeneration of trabecular vessels may alleviate ischemic injury. However, the origins and developmental mechanisms of trabecular vessels remain unknown. Here, we show that murine ventricular endocardial cells generate trabecular vessels through an "angioEMT" mechanism. Time course fate mapping defined a specific wave of trabecular vascularization by ventricular endocardial cells. Single-cell transcriptomics and immunofluorescence identified a subpopulation of ventricular endocardial cells that underwent endocardial-mesenchymal transition (EMT) before these cells generated trabecular vessels. Ex vivo pharmacological activation and in vivo genetic inactivation experiments identified an EMT signal in ventricular endocardial cells involving SNAI2-TGFB2/TGFBR3, which was a prerequisite for later trabecular-vessel formation. Additional loss- and gain-of-function genetic studies showed that VEGFA-NOTCH1 signaling regulated post-EMT trabecular angiogenesis by ventricular endocardial cells. Our finding that trabecular vessels originate from ventricular endocardial cells through a two-step angioEMT mechanism could inform better regeneration medicine for coronary heart disease.

Keywords: SNAI2; TGFBR3; angioEMT; compact myocardium; compact vessel; coronary angiogenesis; coronary-vessel development; trabecular myocardium; trabecular-vessel; ventricular endocardial cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Endocardium*
  • Endothelial Cells
  • Heart Ventricles
  • Heart*
  • Mice
  • Myocardium